Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture.
about
Asymmetric HIV-1 co-receptor use and replication in CD4(+) T lymphocytesMacrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmissionPathogenesis of human immunodeficiency virus infectionAccess of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1Dynamics of HIV-containing compartments in macrophages reveal sequestration of virions and transient surface connectionsUnusual distribution of mutations associated with serial bottleneck passages of human immunodeficiency virus type 1Characterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient.Distinct human immunodeficiency virus strains in the bone marrow are associated with the development of thrombocytopenia.HIV-1 with multiple CCR5/CXCR4 chimeric receptor use is predictive of immunological failure in infected children.V3 loop sequence space analysis suggests different evolutionary patterns of CCR5- and CXCR4-tropic HIV.Different tempo and anatomic location of dual-tropic and X4 virus emergence in a model of R5 simian-human immunodeficiency virus infection.Envelope-dependent restriction of human immunodeficiency virus type 1 spreading in CD4(+) T lymphocytes: R5 but not X4 viruses replicate in the absence of T-cell receptor restimulationKinetic factors control efficiencies of cell entry, efficacies of entry inhibitors, and mechanisms of adaptation of human immunodeficiency virusAnalysis of the temporal relationship between human immunodeficiency virus type 1 quasispecies in sequential blood samples and various organs obtained at autopsyThe cell tropism of human immunodeficiency virus type 1 determines the kinetics of plasma viremia in SCID mice reconstituted with human peripheral blood leukocytes.Virological and molecular demonstration of human immunodeficiency virus type 2 vertical transmissionEvolution of syncytium-inducing and non-syncytium-inducing biological virus clones in relation to replication kinetics during the course of human immunodeficiency virus type 1 infection.The role of macrophages in the development and progression of AIDS-related non-Hodgkin lymphoma.Variants from the diverse virus population identified at seroconversion of a clade A human immunodeficiency virus type 1-infected woman have distinct biological properties.Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropismIn vivo monocyte tropism of pathogenic feline immunodeficiency virusesAnalysis of the critical domain in the V3 loop of human immunodeficiency virus type 1 gp120 involved in CCR5 utilization.Dendritic cell-specific intercellular adhesion molecule-3 grabbing nonintegrin mediates HIV-1 infection of and transmission by M2a-polarized macrophages in vitroCoreceptor and cytokine concentrations may not explain differences in disease progression observed in HIV-1 clade A and D infected Ugandans.Adoption of an "open" envelope conformation facilitating CD4 binding and structural remodeling precedes coreceptor switch in R5 SHIV-infected macaques.Switching of inferred tropism caused by HIV during interruption of antiretroviral therapy.Macrophage-tropic simian/human immunodeficiency virus chimeras use CXCR4, not CCR5, for infections of rhesus macaque peripheral blood mononuclear cells and alveolar macrophagesEffect of CCR5-Δ32 heterozygosity on HIV-1 susceptibility: a meta-analysis.Human immunodeficiency virus type 1 neutralization measured by flow cytometric quantitation of single-round infection of primary human T cells.Putative roles of purinergic signaling in human immunodeficiency virus-1 infectionIncreased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120.Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies.Complexity and dynamics of HIV-1 chemokine receptor usage in a multidrug-resistant adolescentRisk of breast cancer with CXCR4-using HIV defined by V3 loop sequencingThe number of CCR5 expressing CD4+ T lymphocytes is lower in HIV-infected long-term non-progressors with viral control compared to normal progressors: a cross-sectional study.Effect of amino acid substitution of the V3 and bridging sheet residues in human immunodeficiency virus type 1 subtype C gp120 on CCR5 utilization.R5X4 HIV-1 coreceptor use in primary target cells: implications for coreceptor entry blocking strategies.Selective transmission of R5 HIV-1 variants: where is the gatekeeper?Intrinsic obstacles to human immunodeficiency virus type 1 coreceptor switching.Plasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection.
P2860
Q21245460-FFC9F045-91A3-4ADB-BFB7-F9A4CEFDC86CQ22241902-51C8DD65-139D-49FF-84E2-02BEE88CA963Q24634681-8407486C-BDB7-46B2-AD82-93DE53F403ECQ24645530-A74CDBC1-9165-494B-BF74-5A3803C96E35Q27311049-93D7D1F0-05E8-4A50-A50B-1A6A0EF4F8E3Q27469694-0A29A161-5C5A-4E7A-9404-9A8E66C454B6Q30322838-B966E940-1380-41A1-B4DD-E3DF191BF57DQ33328140-60054299-C3A0-4DD5-8894-EB0234086D46Q33372329-3D8DB288-B248-4A28-AE6A-9D1AF22A9FC3Q33509526-0DD58FC0-0DEB-43E9-82B1-4D225437E421Q33558676-472F6FC0-7A4C-4D40-8EEB-C8042A90D255Q33649801-A87DD571-EB1C-4680-9387-1442BE27DCC1Q33707328-70CD765C-4F0F-40F5-9551-BDA1FEFD1588Q33782045-69FA7AD7-6FCC-4C7B-814F-84FED170A71AQ33782350-DBAE70F6-7D3A-4090-8AD9-37D2FDCFDEA2Q33783504-A55677E6-6A3E-4543-B4C8-5B89001AF83FQ33784321-1BF2EBC2-F841-43BC-AF0F-B091F58C1C2FQ33805288-4DBD6B1A-ED29-4950-9FCE-2E9BC8903903Q33814773-52D2FAC0-583D-4F16-9BEA-1A869DC215E2Q33815193-7F867A59-40BE-4A30-B797-0B9DCE8D4880Q33817827-A710C56F-504F-400A-B9B3-DB9543A562DFQ33819515-93923EC6-007A-44F5-AA9E-C23D08B2D0E0Q33922449-651274F7-DAB8-4E91-9598-F4D32F72E381Q33927434-869B8C43-0307-411C-ADB0-51FDC883FAA8Q33961448-BA2C268D-3FD5-4F8E-8D11-3612927B7D47Q33963459-5FCE716B-8696-4494-B228-574C744ADE2AQ34226885-F23183F8-F605-44A9-9F18-D1D83771DA8BQ34230435-D2F298AF-8697-4E88-84BC-71D320F44B64Q34338761-4F2211FB-979D-403C-BA11-8447649C00B4Q34446486-397D1083-2E2D-469D-94C6-837B5345096DQ34464860-88F0D6E7-F596-4ECB-9971-D6296DE2EC88Q34553676-C576EA25-DDFC-4BB5-8899-BE56EF67B384Q34606488-937259CA-841C-453A-8857-A36C8E870341Q34674367-B0E0AA89-FC25-4F8B-8BC5-C3308F45A9D0Q34740235-BF89BA35-2741-4212-A094-E5A0156F8C38Q34744722-A6E1A6C5-87A2-44EA-9F6C-8B3AAF12E951Q35018129-7A36A321-4FE2-4339-9D4E-C64206265733Q35018140-C651F94A-7EC2-46BF-97B5-932AC8FB75B6Q35122466-510B3199-44C8-46BC-8C9C-307E16F111ECQ35140678-50A72262-785E-43B2-A7CB-A1758DD23900
P2860
Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Monocytotropic human immunodef ...... ity in primary T-cell culture.
@en
Monocytotropic human immunodeficiency virus type 1
@nl
type
label
Monocytotropic human immunodef ...... ity in primary T-cell culture.
@en
Monocytotropic human immunodeficiency virus type 1
@nl
prefLabel
Monocytotropic human immunodef ...... ity in primary T-cell culture.
@en
Monocytotropic human immunodeficiency virus type 1
@nl
P2093
P2860
P1433
P1476
Monocytotropic human immunodef ...... ity in primary T-cell culture.
@en
P2093
Kootstra NA
Schuitemaker H
Tersmette M
de Goede RE
P2860
P304
P407
P577
1991-01-01T00:00:00Z